HiberGene Diagnostics

company

About

HiberGene Diagnostics develops, manufactures and markets molecular diagnostic tests for human infectious diseases.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
€2M
Industries
Biotechnology,Health Diagnostics,Manufacturing,Medical
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

Hibergene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology.

The company has a growing portfolio of tests, with tests for Meningococcus and Group B Streptococcus already available. In addition, Hibergene has an active research pipeline from which the company expects to release a number of tests on a yearly basis.

The tests meet a significant unmet clinical need allowing clinicians to rapidly, accurately and easily detect human infectious diseases in a near patient setting.

The company CEO is Brendan Farrell, an industry veteran, who was a founder of Trinity Biotech. The company is headquartered in Ireland and its investors include a number of institutions and private investors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2M
HiberGene Diagnostics has raised a total of €2M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2015 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 2, 2015 Series A €2M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
HiberGene Diagnostics is funded by 1 investors. Kernel Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kernel Capital Series A